ClinicalTrials.gov record
Recruiting Phase 1Phase 2 Interventional

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

ClinicalTrials.gov ID: NCT05320198

Public ClinicalTrials.gov record NCT05320198. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 7:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

RALLY-MF: A Phase 1b/2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of DISC-0974 in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

Study identification

NCT ID
NCT05320198
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Disc Medicine, Inc
Industry
Enrollment
150 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 5, 2022
Primary completion
Aug 31, 2026
Completion
Aug 31, 2026
Last update posted
Apr 30, 2026

2022 – 2026

United States locations

U.S. sites
22
U.S. states
15
U.S. cities
21
Facility City State ZIP Site status
City of Hope - Duarte Duarte California 91010 Recruiting
City of Hope - Lennar Irvine California 92618 Recruiting
University of Colorado Anschutz Medical Campus Aurora Colorado 80045 Recruiting
Mayo Clinic Jacksonville Jacksonville Florida 32224 Recruiting
Sylvester Cancer Center - U Miami Miami Florida 33136 Recruiting
Moffitt Cancer Center Tampa Florida 33612 Recruiting
Emory Winship Cancer Institute Atlanta Georgia 30322 Recruiting
University of Michigan Ann Arbor Michigan 48109 Recruiting
Mayo Clinic Rochester Rochester Minnesota 55905 Recruiting
Washington University St.Louis St Louis Missouri 63110 Recruiting
Memorial Sloan Kettering Cancer Center New York New York 10021 Recruiting
Icahn School of Medicine at Mount Sinai New York New York 10029 Recruiting
Atrium Health Wake Forest Baptist Winston-Salem North Carolina 27157 Recruiting
Gabrail Cancer Center Research Canton Ohio 44718 Terminated
Cleveland Clinic Cleveland Ohio 44195 Recruiting
The Ohio State University Columbus Ohio 43201 Recruiting
Oregon Health and Science University Portland Oregon 97239 Recruiting
Sargon Research - Pennsylvania Cancer Specialists and Research Center Gettysburg Pennsylvania 17325 Withdrawn
University of Pennsylvania Philadelphia Pennsylvania 19104 Recruiting
MD Anderson Houston Texas 77030 Recruiting
University of Washington Seattle Washington 98109 Recruiting
Medical College of Wisconsin Milwaukee Wisconsin 53226 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05320198, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 30, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05320198 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →